Tree News · 2026-10-25 07:30 UTC

BioNTech, Bristol Myers Squibb Report Encouraging Phase 2 Data for Pumitamig in Advanced NSCLC After Immunotherapy Plus Chemotherapy Progression

Loading the story on Tree News…